Pfizer’s New Executive Committee Streamlines Upper Management

Global Pharmaceuticals President Katen, General Counsel Kindler and CFO Shedlarz will become vice chairmen. Katen will now have oversight of the company’s R&D, manufacturing and licensing activities. Shedlarz will lose CFO title but pick up responsibility for human resources.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet